BChE has been demonstrated to be strongly linked with aberrant β-amyloid (Aβ) deposition.12 Numerous researches have indicated that BChE inhibition may serve as a viable approach for the treatment of advanced AD.13 Consequently, AChE and BChE inhibitors are extensively employed in the treatment of AD. This evidence concerns the gene ACHE and Alzheimer disease.